ArticleJournal of public health (Oxford, England)2017
The future of dementia risk reduction research: barriers and solutions.
Article in Journal of public health (Oxford, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 20 citations in OpenAlex.
- The pathogenesis of cerebral small vessel disease and vascular cognitive impairment.Physiological reviews · 2025Review
- Effects of Mindfulness-Based Interventions (MBIs) in Patients with Early-Stage Alzheimer's Disease: A Pilot Study.Brain sciences · 2023Article
- Brain atrophy in middle age using magnetic resonance imaging scans from Japan's health screening programme.Brain communications · 2022Article
- Rates, risks and routes to reduce vascular dementia (R4vad), a UK-wide multicentre prospective observational cohort study of cognition after stroke: Protocol.European stroke journal · 2021Article
- The Cognitive & Leisure Activity Scale (CLAS): A new measure to quantify cognitive activities in older adults with and without cognitive impairment.Alzheimer's & dementia (New York, N. Y.) · 2021Article
- The Resilience Index: A Quantifiable Measure of Brain Health and Risk of Cognitive Impairment and Dementia.Journal of Alzheimer's disease : JAD · 2021Article
- The Effect of Baseline Patient and Caregiver Mindfulness on Dementia Outcomes.Journal of Alzheimer's disease : JAD · 2021Article
- Implementing dementia risk reduction in primary care: a preliminary conceptual model based on a scoping review of practitioners' views.Primary health care research & development · 2019Article
- Brain Health and Dementia Prevention: A Mixed-method Analysis.American journal of health behavior · 2019Article
- N-of-1 Clinical Trials in Nutritional Interventions Directed at Improving Cognitive Function.Frontiers in nutrition · 2019Review
- Synergistic Effects of Curcumin and Piperine as Potent Acetylcholine and Amyloidogenic Inhibitors With Significant Neuroprotective Activity in SH-SY5Y CellsFrontiers in aging neuroscience · 2019Article
- Midlife Psychological Well-Being and its Impact on Cognitive Functioning Later in Life: An Observational Study Using a Female British Birth Cohort.Journal of Alzheimer's disease : JAD · 2019Observational
- Proactive approaches to identifying dementia and dementia risk; a qualitative study of public attitudes and preferences.BMJ open · 2018Article
- Prevention of Alzheimer's Disease: Lessons Learned and Applied.Journal of the American Geriatrics Society · 2017Article
- An Agenda for Addressing Multimorbidity and Racial and Ethnic Disparities in Alzheimer's Disease and Related Dementia.American journal of Alzheimer's disease and other dementiasArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWe examine why dementia prevention and risk reduction are relatively underfunded and suggest potential remediation strategies. The paper is aimed at researchers, funders and policy-makers, both within dementia and also the wider health prevention field.
methodsA discussion-led workshop, attended by 58 academics, clinicians, funders and policy-makers.
resultsThe key barriers identified were the gaps in understanding the basic science of dementia; the complex interplay between individual risk factors; variations in study methodology; disincentives to collaboration; a lack of research capacity and leadership and the broader stigma of the condition. Recommendations were made to encourage strategic leadership, provide greater support for grant applications, promote collaboration and support randomized control trials for the research field.
conclusionHaving identified the barriers, the key challenge is how to implement the potential solutions. This will require engagement with decision-makers within funding, policy and research to ensure that action takes place.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.